Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30530801

Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2019 Mar 7
First author
Burger JA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2019 Mar 7;133(10):1003-1004. doi: 10.1182/blood-2019-01-892695.
    note
    Source null
    related pmid
    30846506
    relationship
    Comment in

Authors and identifiers

  1. name
    Burger JA
    type
    Author
  2. name
    Sivina M
    type
    Author
  3. name
    Jain N
    type
    Author
  4. name
    Kim E
    type
    Author
  5. name
    Kadia T
    type
    Author
  6. name
    Estrov Z
    type
    Author
  7. name
    Nogueras-Gonzalez GM
    type
    Author
  8. name
    Huang X
    type
    Author
  9. name
    Jorgensen J
    type
    Author
  10. name
    Li J
    type
    Author
  11. name
    Cheng M
    type
    Author
  12. name
    Clow F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Burger JA
    type
    Author
  2. name
    Sivina M
    type
    Author
  3. name
    Jain N
    type
    Author
  4. name
    Kim E
    type
    Author
  5. name
    Kadia T
    type
    Author
  6. name
    Estrov Z
    type
    Author
  7. name
    Nogueras-Gonzalez GM
    type
    Author
  8. name
    Huang X
    type
    Author
  9. name
    Jorgensen J
    type
    Author
  10. name
    Li J
    type
    Author
  11. name
    Cheng M
    type
    Author
  12. name
    Clow F
    type
    Author
bibliography ids
  1. nci-bib-873b023c4024bd6cb96b6d52
book metadata
content sha256
2f709d1858007fdc79af3999c22e23116e7a671ab7a0fcfd8a26b3d7abcb43b6
document type
citation
dois
  1. 10.1182/blood-2018-10-879429
electronic publication date
display
2018 Dec 7
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30530801
immutable id
pubmed:30530801@2f709d1858007fdc79af3999c22e23116e7a671ab7a0fcfd8a26b3d7abcb43b6
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
10
name
Blood
nlm unique id
7603509
pages
1011-1019
volume
133
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2019 Mar 7;133(10):1003-1004. doi: 10.1182/blood-2019-01-892695.
    note
    Source null
    related pmid
    30846506
    relationship
    Comment in
outcomes validated
false
pmid
30530801
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
2757af9f3ae2983e6fbd7d2dd1ca08e94d509e259be9f56f1d467fd042cd7157
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2019 Mar 7
precision
day
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30530801/
title
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia.

Preserved source evidence · Not medical advice